Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Acad Dermatol ; 55(6): 1092-4, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17097406

ABSTRACT

Topical therapeutic options for cutaneous squamous cell carcinoma in situ include 5-fluorouracil cream and imiquimod cream. Such treatment may be preferable to surgical or destructive modalities in certain anatomic locations and in instances where patients are unwilling or poor surgical candidates. We present 4 such patients with cutaneous squamous cell carcinoma in situ involving a digit. Each patient failed treatment with imiquimod cream as monotherapy. In addition, two patients failed treatment with 5-fluorouracil cream as monotherapy. All 4 responded completely to 5-fluorouracil and imiquimod cream as combination therapy. In patients who have failed monotherapy with a topical agent for cutaneous squamous cell carcinoma in situ, combination treatment using both topical 5-fluorouracil cream and imiquimod cream may be considered as an alternative therapeutic strategy.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma in Situ/drug therapy , Carcinoma, Squamous Cell/drug therapy , Fingers , Skin Neoplasms/drug therapy , Administration, Cutaneous , Aged , Aminoquinolines/administration & dosage , Aminoquinolines/pharmacology , Antimetabolites, Antineoplastic/pharmacology , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Cytokines/physiology , Drug Evaluation , Drug Synergism , Fluorouracil/administration & dosage , Fluorouracil/pharmacology , Humans , Imiquimod , Male , Middle Aged , Ointments , Prodrugs/pharmacokinetics , Remission Induction , Toll-Like Receptor 7/antagonists & inhibitors , Toll-Like Receptor 8/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...